Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
hACE221-55A36K-F40E
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
VHH VE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EV
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EEE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH EE
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
aRBD-2-5
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
S309
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
VHH W
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH V
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH U
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
VHH E
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021
Cynaroside
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021
Oroxylin A
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/15/2021
NBP11
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
Cilgavimab
Emergency use authorization Experimental Antiviral Jun/18/2022
6-beta-D-Glucopyranosyl-4',5-dihydroxy-7-methoxyflavone
Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021
Qing Fei Pai Du Tang
Potential treatment - clinical evidence Natural product Antiviral Feb/28/2021
1-{3-[2-Hydroxy-3-(4-methylpiperidino)propoxy]phenoxy}-3-(4-methylpiperidino)-2-propanol
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021
NBP10
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/14/2021
VH-Fc ab8
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021